Diagnosis

CSIRO’s diagnostics research and development activity aims to reduce the impacts of some of Australia’s major diseases through earlier diagnosis.

CSIRO’s health-related research utilises sets of skills from across the organisation to develop new products, strategies and technologies. A better understanding of emerging diseases and conditions will help in their prevention, detection and management.

CSIRO today welcomed the launch of the Australian e-Health Research Centre (AEHRC) as a national venture, supported by A$20 million in funding from the Federal and Queensland governments.

One of the major contributors to the development and implementation of Canada’s electronic health records system, Richard C Alvarez, has been appointed an Honorary Fellow of the Australian e-Health Research Centre in Brisbane.

The inaugural Australian Crystallisation course will be held at Melbourne University with lectures at Bio 21 between the 8-12 December 2008.

CSIRO is working to develop the most sensitive, accurate and timely diagnostic tests. These are critical to any eradication campaign in the event of an animal disease outbreak.

Information obtained during clinical treatment can be valuable for clinical and medical research, but accessing and querying it is complicated by the different ways it is collected and stored. CSIRO is creating software tools to solve these problems.

CSIRO’s biomedical imaging team are working to improve the effectiveness of therapies such as surgery or radiotherapy using information gathered from three dimensional images.

CSIRO's NanoBang™ is a medical diagnostic tool that is both quick and quantitative.

In this video extract from the television program Catalyst, CSIRO's Dr Michael Fenech says that damage to the genome is a fundamental disease that can be diagnosed and treated. (8:00)

A video showing an interview of the Kolling Institute's Kerrie MacDonald, as she speaks about how the Kolling Institute and CSIRO have discovered genes that differentiate between different types of brain tumours. (0:49)

Dr Caroline Kerr is a research scientist with extensive experience studying the link between genes and stress in livestock animals. She is currently working on a project to develop tools to detect colorectal cancer in humans.

The nanobiotechnology program led by Dr Ted McMurchie has the potential to develop new biosensors to diagnose human diseases and disorders. Such biosensors mimic the processes carried out by cell membrane proteins.

The improvements in diagnostics and biomarkers with hyperspectral imaging are described in this document. It describes CSIRO hyperspectral imaging solutions for fast and reliable means of characterising the biochemistry in tissue, either to diagnose disease or to identify specific metabolic processes. (2 pages)

This fact sheet details the use of rabbit calicivirus disease (RCD) as a biological control for rabbits in Australia. (2 pages)

This fact sheet provides information about equine influenza and the outbreak of disease which occurred in Australia during 2007.